Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Arbuthnot Banking Group Plc
Financials
The power ranger of relationship deposit banking
By
Mark Thomas
22 Jul 2022
Tissue Regenix
Life Sciences
Strong 1H’22 sales suggest upside potential
19 Jul 2022
Punching above their weight?
By
Keith Hiscock
11 Jul 2022
Cizzle Biotechnology
Life Sciences
Considerable progress in first year since listing
By
Dr Martin Hall
11 Jul 2022
Fidelity Asian Values Plc
Investment Companies
Asia: more appealing than ever
By
Mark Thomas
05 Jul 2022
The Monthly: July 2022
05 Jul 2022
International Biotechnology Trust
Life Sciences
M&A activity on the rise
By
Dr Martin Hall
30 Jun 2022
Volta Finance
Investment Companies
Hardman presentation: carpe diem
By
Mark Thomas
29 Jun 2022
Fidelity China Special Situations Plc
Investment Companies
Eight questions for 20 July AGM
By
Mark Thomas
29 Jun 2022
Renewables
Voluntary Carbon Markets – LSE: Thinking outside its box
By
Nigel Hawkins
13 Jun 2022
ICG Enterprise Trust
Investment Companies
FY’22: you couldn’t ask for more
By
Mark Thomas
07 Jun 2022
Prev
1
...
20
21
22
23
24
...
84
Next
